These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23041719)

  • 1. Haematological features in Barth syndrome.
    Finsterer J; Frank M
    Curr Opin Hematol; 2013 Jan; 20(1):36-40. PubMed ID: 23041719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial defects lie at the basis of neutropenia in Barth syndrome.
    van Raam BJ; Kuijpers TW
    Curr Opin Hematol; 2009 Jan; 16(1):14-9. PubMed ID: 19057200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography.
    Acehan D; Xu Y; Stokes DL; Schlame M
    Lab Invest; 2007 Jan; 87(1):40-8. PubMed ID: 17043667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation and natural history of Barth Syndrome: An overview.
    Taylor C; Rao ES; Pierre G; Chronopoulou E; Hornby B; Heyman A; Vernon HJ
    J Inherit Metab Dis; 2022 Jan; 45(1):7-16. PubMed ID: 34355402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia in Barth syndrome: characteristics, risks, and management.
    Steward CG; Groves SJ; Taylor CT; Maisenbacher MK; Versluys B; Newbury-Ecob RA; Ozsahin H; Damin MK; Bowen VM; McCurdy KR; Mackey MC; Bolyard AA; Dale DC
    Curr Opin Hematol; 2019 Jan; 26(1):6-15. PubMed ID: 30451719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the understanding of Barth syndrome.
    Aprikyan AA; Khuchua Z
    Br J Haematol; 2013 May; 161(3):330-8. PubMed ID: 23432031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis.
    Kuijpers TW; Maianski NA; Tool AT; Becker K; Plecko B; Valianpour F; Wanders RJ; Pereira R; Van Hove J; Verhoeven AJ; Roos D; Baas F; Barth PG
    Blood; 2004 May; 103(10):3915-23. PubMed ID: 14764526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical laboratory studies in Barth Syndrome.
    Vernon HJ; Sandlers Y; McClellan R; Kelley RI
    Mol Genet Metab; 2014 Jun; 112(2):143-7. PubMed ID: 24751896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics Reveals New Mechanisms for Pathogenesis in Barth Syndrome and Introduces Novel Roles for Cardiolipin in Cellular Function.
    Sandlers Y; Mercier K; Pathmasiri W; Carlson J; McRitchie S; Sumner S; Vernon HJ
    PLoS One; 2016; 11(3):e0151802. PubMed ID: 27015085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barth Syndrome with Late-Onset Cardiomyopathy: A Missed Opportunity for Diagnosis.
    Woiewodski L; Ezon D; Cooper J; Feingold B
    J Pediatr; 2017 Apr; 183():196-198. PubMed ID: 28108107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease.
    Agarwal P; Cole LK; Chandrakumar A; Hauff KD; Ravandi A; Dolinsky VW; Hatch GM
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filgrastim treatment of HIV-infected patients improves neutrophil function.
    Pitrak DL
    AIDS; 1999; 13 Suppl 2():S25-30. PubMed ID: 10596678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological & psychological aspects of Barth syndrome: Clinical manifestations and potential pathogenic mechanisms.
    Olivar-Villanueva M; Ren M; Phoon CKL
    Mitochondrion; 2021 Nov; 61():188-195. PubMed ID: 34197965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant myeloid transformation in congenital forms of neutropenia.
    Freedman MH; Alter BP
    Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of granulocyte colony stimulating factor on neutrophil functions in children with neutropenia after chemotherapy in the course of neoplasma.
    Czygier M; Dakowicz Ł; Szmitkowski M
    Adv Med Sci; 2007; 52():143-6. PubMed ID: 18217407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal levels of constitutive and death receptor-mediated apoptosis of peripheral blood neutrophils from patients with chronic idiopathic neutropenia.
    Garwicz D; Palmblad J; Fadeel B
    Clin Immunol; 2007 Mar; 122(3):349-55. PubMed ID: 17188576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor have differential effects on neonatal and adult neutrophil survival and function.
    Molloy EJ; O'Neill AJ; Grantham JJ; Sheridan-Pereira M; Fitzpatrick JM; Webb DW; Watson RW
    Pediatr Res; 2005 Jun; 57(6):806-12. PubMed ID: 15718363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bayesian Analysis to Determine the Prevalence of Barth Syndrome in the Pediatric Population.
    Miller PC; Ren M; Schlame M; Toth MJ; Phoon CKL
    J Pediatr; 2020 Feb; 217():139-144. PubMed ID: 31732128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful mechanical circulatory support for 251 days in a child with intermittent severe neutropenia due to Barth syndrome.
    Dedieu N; Giardini A; Steward CG; Fenton M; Karimova A; Hsia TY; Burch M
    Pediatr Transplant; 2013 Mar; 17(2):E46-9. PubMed ID: 23190323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.